Sandostatin LAR Depot
octreotide acetate · KIT · Novartis Pharmaceuticals Corporation
Sandostatin LAR Depot is a kit containing octreotide acetate. Manufactured by Novartis Pharmaceuticals Corporation.
Key Facts
- Brand Name
- Sandostatin LAR Depot
- Generic Name
- octreotide acetate
- NDC Code (Product)
0078-0825- Manufacturer
- Novartis Pharmaceuticals Corporation
- Dosage Form
- KIT
- Marketing Status
- Application #
- NDA021008
- Marketing Start
- 07/22/2016
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is Sandostatin LAR Depot used for?
Sandostatin LAR Depot contains octreotide acetate. It is a kit taken as directed. Consult your doctor for specific uses.
Is Sandostatin LAR Depot a controlled substance?
Sandostatin LAR Depot is not classified as a controlled substance by the DEA.
What is the generic name for Sandostatin LAR Depot?
The generic name for Sandostatin LAR Depot is octreotide acetate. There are 10 other brand versions of octreotide acetate.
What is the NDC code for Sandostatin LAR Depot ?
The NDC (National Drug Code) for Sandostatin LAR Depot is 0078-0825, listed by Novartis Pharmaceuticals Corporation.
Other Sandostatin LAR Depot Dosages
Other Octreotide Brands
See all →- OCTREOTIDE ACETATE50 ug/mL23155-687
- Octreotide Acetate1000 ug/mL25021-467
- Octreotide Acetate50 ug/mL71288-566
- Octreotide Acetate100 ug/mL0641-6175
- Octreotide Acetate1000 ug/mL0641-6178
- Octreotide Acetate500 ug/mL68083-560
- Sandostatin50 ug/mL0078-0180
- Octreotide Acetate0480-9259
- Octreotide Acetate500 ug/mL0641-6176
- OCTREOTIDE ACETATE200 ug/mL23155-685
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)